162 related articles for article (PubMed ID: 32578762)
1. DEC1: a potential biomarker of malignant transformation in oral leukoplakia.
Mao T; Xiong H; Hu X; Hu Y; Wang C; Yang L; Huang D; Xia K; Su T
Braz Oral Res; 2020; 34():e052. PubMed ID: 32578762
[TBL] [Abstract][Full Text] [Related]
2. Expression of FAP in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
Li R; Zhang R; Shi X; Jiao X; Li Y; Zhao Y; Liu T; Zhang C
Int Dent J; 2024 Jun; 74(3):581-588. PubMed ID: 38278714
[TBL] [Abstract][Full Text] [Related]
3. Copy Number Alterations Predict Development of OSCC from Oral Leukoplakia.
Cai X; Zhang J; Li L; Liu L; Tang M; Zhou X; Peng C; Li X; Chen X; Xu M; Zhang H; Wang J; Huang Y; Li T
J Dent Res; 2024 Feb; 103(2):138-146. PubMed ID: 38217281
[TBL] [Abstract][Full Text] [Related]
4. [Determination of human papillomavirus in oral leukoplakia,oral lichen planus and oral squamous cell carcinoma].
Cao J; Jin JQ; Deng DJ; Liu HW
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):84-8. PubMed ID: 26885914
[TBL] [Abstract][Full Text] [Related]
5. Expression of programmed cell death-ligand 1 in oral squamous cell carcinoma and oral leukoplakia is associated with disease progress and CD8+ tumor-infiltrating lymphocytes.
Chen XJ; Tan YQ; Zhang N; He MJ; Zhou G
Pathol Res Pract; 2019 Jun; 215(6):152418. PubMed ID: 31027907
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
Varun BR; Ranganathan K; Rao UK; Joshua E
J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093
[TBL] [Abstract][Full Text] [Related]
7. Influence of PD-1/PD-L1 on immune microenvironment in oral leukoplakia and oral squamous cell carcinoma.
Xu SB; Wang MY; Shi XZ; Wang Q; Yu M; Zhang W; Xu XH; Liu LK
Oral Dis; 2023 Nov; 29(8):3268-3277. PubMed ID: 35921211
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of ADAM10 in oral squamous cell carcinoma with metastases.
Stasikowska-Kanicka O; Wągrowska-Danilewicz M; Kulicka P; Danilewicz M
Pol J Pathol; 2018; 69(1):67-72. PubMed ID: 29895129
[TBL] [Abstract][Full Text] [Related]
9. Differences in the response of normal oral mucosa, oral leukoplakia, oral squamous cell carcinoma-derived mesenchymal stem cells, and epithelial cells to photodynamic therapy.
Guo Q; Ji X; Zhang L; Liu X; Wang Y; Liu Z; Jin J; Han Y; Liu H
J Photochem Photobiol B; 2024 Jun; 255():112907. PubMed ID: 38677259
[TBL] [Abstract][Full Text] [Related]
10. E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study.
von Zeidler SV; de Souza Botelho T; Mendonça EF; Batista AC
BMC Cancer; 2014 Dec; 14():972. PubMed ID: 25518919
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppression Induced by Chronic Inflammation and the Progression to Oral Squamous Cell Carcinoma.
Sun Y; Liu N; Guan X; Wu H; Sun Z; Zeng H
Mediators Inflamm; 2016; 2016():5715719. PubMed ID: 28053372
[TBL] [Abstract][Full Text] [Related]
12. T cells are involved in the induction of macrophage phenotypes in oral leukoplakia and squamous cell carcinoma-a preliminary report.
Stasikowska-Kanicka O; Wągrowska-Danilewicz M; Danilewicz M
J Oral Pathol Med; 2018 Feb; 47(2):136-143. PubMed ID: 29108105
[TBL] [Abstract][Full Text] [Related]
13. Quantitative risk stratification of oral leukoplakia with exfoliative cytology.
Liu Y; Li J; Liu X; Liu X; Khawar W; Zhang X; Wang F; Chen X; Sun Z
PLoS One; 2015; 10(5):e0126760. PubMed ID: 25978541
[TBL] [Abstract][Full Text] [Related]
14. The correlation between the expression of differentiated embryo-chondrocyte expressed gene l and oral squamous cell carcinoma.
You J; Lin L; Liu Q; Zhu T; Xia K; Su T
Eur J Med Res; 2014 Apr; 19(1):21. PubMed ID: 24758579
[TBL] [Abstract][Full Text] [Related]
15. [DNA cytometry of exfoliated cells in the diagnosis of oral potential malignant disorders].
Liu Y; Gao Y; Chen XJ; Hua H
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Feb; 51(1):16-20. PubMed ID: 30773538
[TBL] [Abstract][Full Text] [Related]
16. CD8+ and CD163+ infiltrating cells and PD-L1 immunoexpression in oral leukoplakia and oral carcinoma.
Stasikowska-Kanicka O; Wągrowska-Danilewicz M; Danilewicz M
APMIS; 2018 Sep; 126(9):732-738. PubMed ID: 30160018
[TBL] [Abstract][Full Text] [Related]
17. Malignant transformation of oral leukoplakia treated with carbon dioxide laser: a meta-analysis.
Dong Y; Chen Y; Tao Y; Hao Y; Jiang L; Dan H; Zeng X; Chen Q; Zhou Y
Lasers Med Sci; 2019 Feb; 34(1):209-221. PubMed ID: 30443884
[TBL] [Abstract][Full Text] [Related]
18. Laser-capture microdissection and protein extraction for protein fingerprint of OSCC and OLK.
He H; Sun G; Ping F
Artif Cells Blood Substit Immobil Biotechnol; 2009; 37(5):208-13. PubMed ID: 19735007
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-37 expression and its potential role in oral leukoplakia and oral squamous cell carcinoma.
Lin L; Wang J; Liu D; Liu S; Xu H; Ji N; Zhou M; Zeng X; Zhang D; Li J; Chen Q
Sci Rep; 2016 May; 6():26757. PubMed ID: 27225603
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or Ki-67 antigen in oral leukoplakia with or without epithelial dysplasia.
Kurokawa H; Matsumoto S; Murata T; Yamashita Y; Tomoyose T; Zhang M; Fukuyama H; Takahashi T
J Oral Pathol Med; 2003 Oct; 32(9):513-21. PubMed ID: 12969225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
